Chandan Healthcare Limited — Investor Meet, 25-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Chandan Healthcare reported strong FY25 performance with Revenue at ₹232.17 Cr (+30.57% YoY), EBITDA ₹43.38 Cr (18.69% margin), and PAT ₹22.17 Cr (+36.17% YoY, 9.63% margin). The company employs a diversified B2C (37.53%), B2B (39.68%), and B2G (22.80%) model, offering quality pathology and radiology services across 40 diagnostic centers and 360 collection points. Strategic expansion into Tier 2/3 cities in North & Central India, including Delhi, MP, and Chhattisgarh, involves opening 20+ new centers annually. This growth strategy underscores a confident outlook.